AI Shows Promise for Intraoperative Lung Adenocarcinoma Assessment

• by Andrea Surnit

• May 29, 2026

High prevalence of targetable drivers but poor outcomes in lung adenocarcinoma: a real-world cohort from the French West Indies

• by Régine Marlin, Emeline Colomba, Sabrina Pennont, Adel Zouzou, Marlyne Moranton, Nassim Boukadoum, Heriniaina Randriamiarisoa, Jean-Marc Rakotonarivo, Stefanos Bougas, Karim Fard, Soizic Masson, Moustapha Dramé, Jacques Jougon, Mihaela Aldea, Moustapha Agossou

• May 4, 2026

FDA Approves Expanded Liquid Biopsy Panel

Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.

• by Kathryn Wighton

• May 20, 2026

• 2 min

Cancer Is Coming for Younger Adults — and the Field Isn’t Ready

The epidemiological tools built for midlife disease are straining to explain a generational shift

• by Kerri Miller

• April 7, 2026

• 3 min